Enfuvirtide0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Enfuvirtide — research data
Regulatory statusFDA-approved (Fuzeon)
NCAA D1Permitted
Overview
About Enfuvirtide
Mechanism of action
Fusion inhibitor T-20 peptide; prevents HIV envelope gp41 hairpin formation and cell membrane fusion
Safety profile
Injection site reactions nearly universal, bacterial pneumonia; rarely used today · Approved for HIV; injection site reactions in 98% (local, not systemic); hypersensitivity rare
Related pages